amoxicillin has been researched along with Cardiovascular Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwashita, N; Matayoshi, S; Nakano, K; Nomura, R; Otsugu, M; Suehiro, Y | 1 |
| Cao, Y; Dong, L; Iheozor-Ejiofor, Z; Li, C; Liu, W; Lv, Z; Miao, C; Ye, Z | 1 |
| Dewan, M; Goyal, L; Gupta, S; Singla, M | 1 |
| Chan, EW; Chui, CS; Douglas, IJ; Ghebremichael-Weldeselassie, Y; Root, A; Siu, CW; Smeeth, L; Wong, AY; Wong, IC | 1 |
| Alexander, GC; Iyer, G | 2 |
| Blake, Z | 1 |
| Wong, IC | 1 |
| Go, MF | 1 |
| Bedogni, G; Bertoni, G; Ghirarduzzi, A; Iori, I; Silingardi, M; Tincani, E | 1 |
3 review(s) available for amoxicillin and Cardiovascular Diseases
| Article | Year |
|---|---|
Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Chronic Periodontitis; Humans; Metabolic Syndrome; Metronidazole; Primary Prevention; Randomized Controlled Trials as Topic; Secondary Prevention | 2022 |
Is periodontal therapy an effective treatment modality for preventing or managing cardiovascular disease in patients with periodontitis?
Topics: Amoxicillin; Cardiovascular Diseases; Chronic Periodontitis; Female; Humans; Lactation; Metronidazole; Pilot Projects; Randomized Controlled Trials as Topic; United States | 2023 |
Treatment and management of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Cardiovascular Diseases; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Rabeprazole; Stomach Neoplasms; Treatment Outcome | 2002 |
7 other study(ies) available for amoxicillin and Cardiovascular Diseases
| Article | Year |
|---|---|
Evaluation of the collagen-binding properties and virulence of killed Streptococcus mutans in a silkworm model.
Topics: Adhesins, Bacterial; Amoxicillin; Animals; Bombyx; Cardiovascular Diseases; Carrier Proteins; Collagen; Dental Caries; Disease Models, Animal; Humans; Muramidase; Saliva; Streptococcal Infections; Streptococcus mutans; Virulence | 2022 |
Cardiovascular outcomes associated with use of clarithromycin: population based study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Middle Aged; Propensity Score; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 2016 |
Cardiovascular risks associated with clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Study provides insufficient evidence of a link between clarithromycin and myocardial infarction.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Editorialists' reply to Blake.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Author's reply to Blake.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Helicobacter pylori, a frequent and potentially dangerous guest in the gastroduodenal mucosa of anticoagulated patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aged; Amoxicillin; Anti-Ulcer Agents; Anticoagulants; Benzimidazoles; Cardiovascular Diseases; Duodenum; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; International Normalized Ratio; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Sulfoxides | 2000 |